<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05034523</url>
  </required_header>
  <id_info>
    <org_study_id>Voxel based MRI in depression</org_study_id>
    <nct_id>NCT05034523</nct_id>
  </id_info>
  <brief_title>Voxel Based Morphometry In Patients With Psychotic Versus Non Psychotic Depression</brief_title>
  <official_title>Voxel Based Morphometry In Patients With Psychotic Versus Non Psychotic Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To examine structural brain changes in patients with depression measured using voxel&#xD;
           based morphometry(VBM) in comparison with healthy subjects.&#xD;
&#xD;
        2. Relation between grey mater volume (GMV) and other structural changes, and the severity&#xD;
           of clinical symptoms.&#xD;
&#xD;
        3. To study if there is structural brain difference between psychotic and non-psychotic&#xD;
           depression&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Depression is a major psychiatric disorder and a leading cause of disability worldwide. The&#xD;
      clinical representation encompasses affective, cognitive and somatic complains such as low&#xD;
      mood, anxiety, lack of pleasure and interest, disturbances of sleep and appetite, decreased&#xD;
      self-esteem, thoughts of guilt, hopelessness, and even suicide.&#xD;
&#xD;
      Major depressive disorder (MDD) with psychotic features (psychotic depression) is a severe&#xD;
      disorder with a lifetime prevalence of 0.35-1% .&#xD;
&#xD;
      Over the last decades, increasing evidence from post-mortem studies and in vivo studies&#xD;
      emerged that mood disorder can induce structural and morphometric changes of the brain The&#xD;
      development of magnetic resonance imaging (MRI) has allowed for more advanced structural&#xD;
      imaging&#xD;
&#xD;
      Several structural magnetic resonance imaging (s MRI) studies have identified key brain areas&#xD;
      involved in MDD. In particular, voxel-based morphometry (VBM), it is helpful in&#xD;
      quantitatively identifying unexpected anatomic changes studies have found that MDD is&#xD;
      associated with widespread local brain abnormalities, mainly affecting the frontal gyrus,&#xD;
      insula, temporal lobes and anterior cingulate gyrus . Structural white matter alterations&#xD;
      have also been reported within the inferior parietal lobule and frontal gyrus .&#xD;
&#xD;
      Many studies are positive about grey matter (GM) volume reductions in various cortical&#xD;
      regions in depressed patients compared to healthy controls . The most consistent findings&#xD;
      appear to be related to GM loss in medial frontal cortex (MFC), anterior cingulate cortex&#xD;
      (ACC) and orbitofrontal cortex (OFC) with less evidence about subcortical structures such as&#xD;
      the amygdala and the hippocampus .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Study the structural brain changes in different areas in patients with psychotic depression and non-psychotic depression.</measure>
    <time_frame>one year</time_frame>
    <description>Investigators will use MRI the voxel based morphometry to measure the volume of different areas in grey and white matter in depressed patients and compare them to structure of brain in healthy group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Examine different variables related to major depressive disorder and their specific relation to structural changes in different areas in brain</measure>
    <time_frame>one year</time_frame>
    <description>Investigators will measure the changes occur in volume of different areas in brain with different types of depression.&#xD;
Investigators will measure the changes in volume of different areas in brain which occur by the effect of psychotic features.&#xD;
Investigators will measure the effect of suicide on changes of volume of different areas of brain.</description>
  </primary_outcome>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Psychotic Depression</condition>
  <condition>Non Psychotic Depression</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>MRI Voxel based morphometry</intervention_name>
    <description>Voxel based morphometry through analysis of 3D T1 weighted sequence to assess total intracranial volume. All participants were scanned on the 1.5Tesla MR scanner (Achieva, Philips Medical Systems, Best, NL) with a 16-channel head coil at the diagnostic radiology department.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study included two groups:&#xD;
&#xD;
        Group (A): patients' group diagnosed with major depressive disorder (MDD) which include&#xD;
        (44) patients aged 18-60 years' old who attended psychiatric outpatient's clinic and who is&#xD;
        admitted in psychiatric unit of Assiut university hospitals. This group is further&#xD;
        subdivided according to DSM 5 Criteria into 2 subgroups: Major depression with psychotic&#xD;
        disorder and Major depression without psychotic disorder.&#xD;
&#xD;
        Group (B): control group which consists of (22) healthy cross matching individuals.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18-60 years old.&#xD;
&#xD;
          2. Based on DSM5 Criteria: MDD with or without psychotic features.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1 • Patients under 18 years old or above 60&#xD;
&#xD;
        2• Pregnant or lactating women.&#xD;
&#xD;
        3• Other current or past major psychiatric disorders&#xD;
&#xD;
        4• History or concurrent neurological disease(seizures) or prior head trauma with evidence&#xD;
        of consequent cognitive impairment.&#xD;
&#xD;
        5• First degree family history of schizophrenia if the participant is less than 33 years&#xD;
        old (mean age of onset of schizophrenia plus two standard deviations) to exclude possible&#xD;
        prodromal phase of schizophrenia.&#xD;
&#xD;
        6• Unstable medical condition (i.e., any active illness that may affect the brain as blood&#xD;
        dyscrasis, lymphomas, endocrinopathies, renal failure, chronic obstructive lung disease,&#xD;
        systemic autoimmune disorders or Malignancy).&#xD;
&#xD;
        7• Patients being treated with steroids or hormonal therapy .&#xD;
&#xD;
        8• Current substances or alcohol use disorders (past diagnosis allowed if in remission for&#xD;
        more than 6 months&#xD;
&#xD;
        9• Contraindications for MRI as:&#xD;
&#xD;
          -  Metal implants or paramagnetic objects contained within the body (including heart&#xD;
             pacemaker or surgical prosthesis)&#xD;
&#xD;
          -  Claustrophobia significant enough to interfere with MRI&#xD;
&#xD;
             10• Refusal of informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yasser Elserogy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Doaa Elhefny, MSC</last_name>
    <phone>+201022388263</phone>
    <email>doaanoors304@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Romany Jabra, MD</last_name>
    <email>romanyhosny@med.aun.edu.eg</email>
  </overall_contact_backup>
  <reference>
    <citation>Sacher J, Neumann J, Fünfstück T, Soliman A, Villringer A, Schroeter ML. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J Affect Disord. 2012 Oct;140(2):142-8. doi: 10.1016/j.jad.2011.08.001. Epub 2011 Sep 3.</citation>
    <PMID>21890211</PMID>
  </reference>
  <reference>
    <citation>Jääskeläinen E, Juola T, Korpela H, Lehtiniemi H, Nietola M, Korkeila J, Miettunen J. Epidemiology of psychotic depression - systematic review and meta-analysis. Psychol Med. 2018 Apr;48(6):905-918. doi: 10.1017/S0033291717002501. Epub 2017 Sep 12.</citation>
    <PMID>28893329</PMID>
  </reference>
  <reference>
    <citation>Lui S, Zhou XJ, Sweeney JA, Gong Q. Psychoradiology: The Frontier of Neuroimaging in Psychiatry. Radiology. 2016 Nov;281(2):357-372. Review.</citation>
    <PMID>27755933</PMID>
  </reference>
  <reference>
    <citation>O'Connor S, Agius M. A systematic review of structural and functional MRI differences between psychotic and nonpsychotic depression. Psychiatr Danub. 2015 Sep;27 Suppl 1:S235-9. Review.</citation>
    <PMID>26417770</PMID>
  </reference>
  <reference>
    <citation>Schmaal L, Veltman DJ, van Erp TG, Sämann PG, Frodl T, Jahanshad N, Loehrer E, Tiemeier H, Hofman A, Niessen WJ, Vernooij MW, Ikram MA, Wittfeld K, Grabe HJ, Block A, Hegenscheid K, Völzke H, Hoehn D, Czisch M, Lagopoulos J, Hatton SN, Hickie IB, Goya-Maldonado R, Krämer B, Gruber O, Couvy-Duchesne B, Rentería ME, Strike LT, Mills NT, de Zubicaray GI, McMahon KL, Medland SE, Martin NG, Gillespie NA, Wright MJ, Hall GB, MacQueen GM, Frey EM, Carballedo A, van Velzen LS, van Tol MJ, van der Wee NJ, Veer IM, Walter H, Schnell K, Schramm E, Normann C, Schoepf D, Konrad C, Zurowski B, Nickson T, McIntosh AM, Papmeyer M, Whalley HC, Sussmann JE, Godlewska BR, Cowen PJ, Fischer FH, Rose M, Penninx BW, Thompson PM, Hibar DP. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry. 2016 Jun;21(6):806-12. doi: 10.1038/mp.2015.69. Epub 2015 Jun 30.</citation>
    <PMID>26122586</PMID>
  </reference>
  <reference>
    <citation>Yuan Y, Zhang Z, Bai F, Yu H, You J, Shi Y, Qian Y, Liu W, Jiang T. Larger regional white matter volume is associated with executive function deficit in remitted geriatric depression: an optimized voxel-based morphometry study. J Affect Disord. 2009 May;115(1-2):225-9. doi: 10.1016/j.jad.2008.09.018. Epub 2008 Oct 21.</citation>
    <PMID>18945494</PMID>
  </reference>
  <reference>
    <citation>Lai CH. Gray matter volume in major depressive disorder: a meta-analysis of voxel-based morphometry studies. Psychiatry Res. 2013 Jan 30;211(1):37-46. doi: 10.1016/j.pscychresns.2012.06.006. Epub 2012 Nov 10.</citation>
    <PMID>23146253</PMID>
  </reference>
  <reference>
    <citation>Arnone D, Job D, Selvaraj S, Abe O, Amico F, Cheng Y, Colloby SJ, O'Brien JT, Frodl T, Gotlib IH, Ham BJ, Kim MJ, Koolschijn PC, Périco CA, Salvadore G, Thomas AJ, Van Tol MJ, van der Wee NJ, Veltman DJ, Wagner G, McIntosh AM. Computational meta-analysis of statistical parametric maps in major depression. Hum Brain Mapp. 2016 Apr;37(4):1393-404. doi: 10.1002/hbm.23108. Epub 2016 Feb 8. Review.</citation>
    <PMID>26854015</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 24, 2021</study_first_submitted>
  <study_first_submitted_qc>August 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>August 29, 2021</last_update_submitted>
  <last_update_submitted_qc>August 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Doaa Noor Eldin Abdelazeem Mohammed</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>Depression</keyword>
  <keyword>Psychotic depression</keyword>
  <keyword>Voxel based morphometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

